New quinoxaline-based VEGFR-2 inhibitors: design, synthesis, and antiproliferative evaluation with in silico docking, ADMET, toxicity, and DFT studies
Alanazi, Mohammed M, Elkady, Hazem, Alsaif, Nawaf A, Obaidullah, Ahmad J, Alkahtani, Hamad M, Alanazi, Manal M, Alharbi, Madhawi A, Eissa, Ibrahim H, Dahab, Mohammed A
Published in RSC advances (06.09.2021)
Published in RSC advances (06.09.2021)
Get full text
Journal Article
Discovery of new quinoxaline-based derivatives as anticancer agents and potent VEGFR-2 inhibitors: Design, synthesis, and in silico study
Alanazi, Mohammed M., Elkady, Hazem, Alsaif, Nawaf A., Obaidullah, Ahmad J., Alanazi, Wael A., Al-Hossaini, Abdulah M., Alharbi, Madhawi A., Eissa, Ibrahim H., Dahab, Mohammed A.
Published in Journal of molecular structure (05.04.2022)
Published in Journal of molecular structure (05.04.2022)
Get full text
Journal Article
New quinoxaline-based VEGFR-2 inhibitors: design, synthesis, and antiproliferative evaluation with docking, ADMET, toxicity, and DFT studies
Alanazi, Mohammed M, Elkady, Hazem, Alsaif, Nawaf A, Obaidullah, Ahmad J, Alkahtani, Hamad M, Alanazi, Manal M, Alharbi, Madhawi A, Eissa, Ibrahim H, Dahab, Mohammed A
Published in RSC advances (12.10.2021)
Published in RSC advances (12.10.2021)
Get full text
Journal Article